These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4975199)

  • 1. [Bacteriostatic action of isonicotyl hydrazone-phospho-5'-pyridoxal on M.tuberculosis in vitro].
    Gonnard P; Ayoun M
    Rev Fr Etud Clin Biol; 1968 Oct; 13(8):802-5. PubMed ID: 4975199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Accelerated determination of blood bacteriostatic activity in patients with tuberculosis by using the semiliquid culture medium].
    Manicheva OA
    Probl Tuberk Bolezn Legk; 2003; (9):26-9. PubMed ID: 14598523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempted use of a new rapid easy method of detecting bacilli of tuberculosis and determination of their drug-sensitivity.
    Tyrakowska J
    Pol Med J; 1969; 8(1):82-8. PubMed ID: 4976571
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance in M. tuberculosis cultures determined by the Steenken MIC and Canetti proportion tests.
    Montalbine V; Collins FM; Doster B
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):78-80. PubMed ID: 4985844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 7. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
    Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
    J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dependence of the inhibition titre on the duration of incubation in determination of the resistance of M. tuberculosis to antituberculotics on Löwenstein-Jensen medium].
    Bartmann K; Abel U; Hart R
    Zentralbl Bakteriol Orig; 1966 Dec; 201(4):538-48. PubMed ID: 4966714
    [No Abstract]   [Full Text] [Related]  

  • 14. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 15. [On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(2):105-15. PubMed ID: 4981145
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
    Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
    J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.